EG20513A - Bicyclic tetrahydro pyrazolopyridines - Google Patents

Bicyclic tetrahydro pyrazolopyridines

Info

Publication number
EG20513A
EG20513A EG40294A EG40294A EG20513A EG 20513 A EG20513 A EG 20513A EG 40294 A EG40294 A EG 40294A EG 40294 A EG40294 A EG 40294A EG 20513 A EG20513 A EG 20513A
Authority
EG
Egypt
Prior art keywords
pyrazolopyridines
bicyclic
bicyclic tetrahydro
tetrahydro pyrazolopyridines
tetrahydro
Prior art date
Application number
EG40294A
Other languages
English (en)
Inventor
Allen G J Duplantier
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG20513A publication Critical patent/EG20513A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EG40294A 1993-07-06 1994-07-05 Bicyclic tetrahydro pyrazolopyridines EG20513A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8829293A 1993-07-06 1993-07-06

Publications (1)

Publication Number Publication Date
EG20513A true EG20513A (en) 1999-06-30

Family

ID=22210524

Family Applications (1)

Application Number Title Priority Date Filing Date
EG40294A EG20513A (en) 1993-07-06 1994-07-05 Bicyclic tetrahydro pyrazolopyridines

Country Status (20)

Country Link
EP (1) EP0707585A1 (pt)
JP (1) JP2944048B2 (pt)
KR (1) KR100228949B1 (pt)
CN (1) CN1048015C (pt)
AU (1) AU695301B2 (pt)
BR (1) BR9406946A (pt)
CA (1) CA2166721C (pt)
CZ (1) CZ3696A3 (pt)
EG (1) EG20513A (pt)
FI (1) FI943208A (pt)
HU (1) HUT74170A (pt)
IL (1) IL110175A (pt)
MX (1) MX9405132A (pt)
NO (1) NO305029B1 (pt)
NZ (1) NZ266525A (pt)
PL (1) PL312426A1 (pt)
RU (1) RU2131876C1 (pt)
TW (1) TW316904B (pt)
WO (1) WO1995001980A1 (pt)
ZA (1) ZA944844B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1050129C (zh) * 1994-10-20 2000-03-08 美国辉瑞有限公司 二环四氢吡唑并吡啶和其作为药物的应用
DK0837860T3 (da) * 1995-06-06 2002-05-27 Pfizer Tricykliske 5,6-dihydro-9H-pyrazolo[3,4-c]-1,2,4-triazolo-[4,3-alfa]pyridiner
AP932A (en) * 1996-08-26 2001-02-02 Pfizer Tricyclic 5,6-dihydro-9H-pyrazolo (3,4c)-1,2,4,-triazolo (4,3-a) pyridines.
CA2264798A1 (en) * 1996-09-04 1998-03-12 Pfizer Inc. Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
US6858616B2 (en) 1998-12-23 2005-02-22 Bristol-Myers Squibb Pharma Company Nitrogen containing heterobicycles as factor Xa inhibitors
CA2349330C (en) 1998-12-23 2009-09-29 Dupont Pharmaceuticals Company Nitrogen containing heterobicycles as factor xa inhibitors
US6326495B2 (en) 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
SI1212089T1 (sl) 1999-08-21 2006-08-31 Altana Pharma Ag Sinergisticna kombinacija roflumilasta in salmeterola
TWI243055B (en) * 2000-04-13 2005-11-11 Nippon Zoki Pharmaceutical Co Pharmaceutical composition for use in treatment of dermatitis
PL213199B1 (pl) * 2000-08-10 2013-01-31 Pharmacia Italia Spa Zwiazek bicyklo-pirazolowy, sposób wytwarzania go, jego kompozycja farmaceutyczna, oraz kombinatoryczna biblioteka chemiczna
US6960595B2 (en) * 2001-03-23 2005-11-01 Bristol-Myers Squibb Pharma Company 5-6 to 5-7 Heterobicycles as factor Xa inhibitors
CA2441772A1 (en) 2001-04-18 2002-10-31 Bristol-Myers Squibb Company 1,4,5,6-tetrahydropyrazolo-¬3,4-c|-pyridin-7-ones as factor xa inhibitors
WO2002085356A1 (en) 2001-04-18 2002-10-31 Bristol-Myers Squibb Company 1, 4, 5, 6-tetrahydropyrazolo-[3, 4-c]-pyrid in-7-ones as factor xa inhibitors
WO2002088122A1 (fr) * 2001-04-26 2002-11-07 Ajinomoto Co., Inc. Composes heterocycliques
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
UA81453C2 (en) 2003-02-27 2008-01-10 Pyrazolopyridine derivates
US7135469B2 (en) * 2003-03-18 2006-11-14 Bristol Myers Squibb, Co. Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
JP2006522151A (ja) 2003-04-01 2006-09-28 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 不妊症におけるホスホジエステラーゼ阻害剤
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
DE102005031580A1 (de) * 2005-07-06 2007-01-11 Aicuris Gmbh & Co. Kg Substituierte Sulfolanylpyrazole und ihre Verwendung
PE20081889A1 (es) * 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EA201391254A1 (ru) 2011-03-01 2014-02-28 Синерджи Фармасьютикалз Инк. Способ получения агонистов гуанилатциклазы c
EP2958577A2 (en) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
PT3004138T (pt) 2013-06-05 2024-06-18 Bausch Health Ireland Ltd Agonistas ultrapuros de guanilato ciclase c, método de produção e utilização dos mesmos
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
CN110357888A (zh) * 2018-04-09 2019-10-22 南京药捷安康生物科技有限公司 杂环磷酸二酯酶抑制剂及其用途
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3365459A (en) * 1964-09-08 1968-01-23 Ciba Geigy Corp Certain tetrahydro pyrazolo-pyridine and pyrazolo-piperidine derivatives
FR1463883A (fr) * 1964-09-08 1966-07-22 Ciba Geigy Procédé de préparation de triaza-composés bicycliques
US3340269A (en) * 1964-09-08 1967-09-05 Ciba Geigy Corp 1-substituted 4-acyl-2, 3-dioxo-piperidine
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines

Also Published As

Publication number Publication date
IL110175A (en) 2000-01-31
CA2166721A1 (en) 1995-01-19
EP0707585A1 (en) 1996-04-24
CN1048015C (zh) 2000-01-05
CA2166721C (en) 1999-07-27
AU6805794A (en) 1995-02-06
NO960056L (no) 1996-01-05
KR960703852A (ko) 1996-08-31
FI943208A0 (fi) 1994-07-05
WO1995001980A1 (en) 1995-01-19
NZ266525A (en) 1997-10-24
JPH08507084A (ja) 1996-07-30
PL312426A1 (en) 1996-04-29
NO960056D0 (no) 1996-01-05
HUT74170A (en) 1996-11-28
RU2131876C1 (ru) 1999-06-20
IL110175A0 (en) 1994-10-07
KR100228949B1 (ko) 1999-11-01
NO305029B1 (no) 1999-03-22
ZA944844B (en) 1996-01-05
CZ3696A3 (en) 1997-06-11
BR9406946A (pt) 1996-08-06
TW316904B (pt) 1997-10-01
FI943208A (fi) 1995-01-07
JP2944048B2 (ja) 1999-08-30
AU695301B2 (en) 1998-08-13
HU9503934D0 (en) 1996-03-28
MX9405132A (es) 1995-01-31
CN1129940A (zh) 1996-08-28

Similar Documents

Publication Publication Date Title
EG20513A (en) Bicyclic tetrahydro pyrazolopyridines
ZA958839B (en) Bicyclic tetrahydro pyrazolopyridines
HU9403364D0 (en) Imidazopyridine
ZA939433B (en) Imidazopyridines
HU9201781D0 (en) Bicyclic repamicines
ZA949664B (en) Imidazopyridines
EP0702671A4 (en) BICYCLIC FIBRINOGEN ANTAGONISTS
HU9601789D0 (en) Pyrazolopyridine adenosine antagonists
AU4123893A (en) Imidazopyridines
AU3019192A (en) Imidazopyridines
ZA943996B (en) Imidazopyridines
ZA932459B (en) Imidazopyridines
ZA942543B (en) Tetrohydro beta-carbolines
ZA937875B (en) Imidazopyridines
EP0745086A4 (en) TRICYCLIC SPIROPIPERIDINES
ZA947314B (en) Tricyclic derivatives
ZA931368B (en) Sulphonylbenzyl-substituted imidazopyridines
HU9500007D0 (en) Tricyclic cepheme derivatives
EP0417059A3 (en) Bicyclic tetrahydroxylated pyrrolizidines
ZA94990B (en) New imidazopyridines
IL119547A0 (en) Imidazopyridine compounds
ZA942352B (en) Spiropiperidine derivatives
ZA9410409B (en) Pyrazolopyridine compound
ZA934289B (en) Imidazopyridines.
GB9116309D0 (en) Bicyclic derivatives